Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Publication of Supplementary Prospectus

24 Jul 2025 12:21

RNS Number : 4565S
Lloyds Banking Group PLC
24 July 2025
 

 

24 July 2025

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplementary Prospectus dated 24 July 2025 (the "Supplementary Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of Lloyds Banking Group plc.

The Supplementary Prospectus should be read and construed in conjunction with the prospectus dated 21 March 2025, as supplemented by the supplementary prospectus dated 1 May 2025 relating to the above-mentioned programme (the "Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4565S_1-2025-7-24.pdf

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

Investor Relations:

Douglas Radcliffe

Group Investor Relations Director

Tel: +44 (0) 20 7356 1571

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate TreasuryKristofer MiddletonHead of Term Issuance and Capital Structuring

Tel: +44 (0) 207 356 1122

Email: Kristofer.Middleton@lloydsbanking.com

 

Group Corporate Affairs:

Matt Smith

Head of Media Relations

Tel: +44 (0) 7788 352 487

Email: matt.smith@lloydsbanking.com

 

Lloyds Banking Group plc

Registered Office

The Mound

Edinburgh EH1 1YZ

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPEAFXLAFDSEFA
Date   Source Headline
29th Aug 20254:19 pmRNSTotal Voting Rights
28th Aug 20255:32 pmRNSTransaction in Own Shares
27th Aug 20255:45 pmRNSTransaction in Own Shares
26th Aug 20255:30 pmRNSTransaction in Own Shares
22nd Aug 20255:22 pmRNSTransaction in Own Shares
22nd Aug 20252:00 pmRNSDirector/PDMR Shareholding
21st Aug 20255:36 pmRNSTransaction in Own Shares
20th Aug 20255:27 pmRNSTransaction in Own Shares
19th Aug 20255:25 pmRNSTransaction in Own Shares
18th Aug 20255:31 pmRNSTransaction in Own Shares
15th Aug 20255:50 pmRNSTransaction in Own Shares
14th Aug 20255:22 pmRNSTransaction in Own Shares
13th Aug 20255:26 pmRNSTransaction in Own Shares
12th Aug 20255:40 pmRNSTransaction in Own Shares
12th Aug 20253:40 pmRNSDirector/PDMR Shareholding
11th Aug 20255:37 pmRNSTransaction in Own Shares
8th Aug 20255:29 pmRNSTransaction in Own Shares
7th Aug 20255:32 pmRNSTransaction in Own Shares
7th Aug 20254:05 pmRNSPublication of a Prospectus
7th Aug 20252:00 pmRNSDirector/PDMR Shareholding
6th Aug 20255:46 pmRNSTransaction in Own Shares
5th Aug 20255:34 pmRNSTransaction in Own Shares
5th Aug 20253:43 pmRNSPublication of Suppl.Prospcts
5th Aug 20253:36 pmRNSPublication of Suppl.Prospcts
4th Aug 20255:39 pmRNSTransaction in Own Shares
4th Aug 20257:00 amRNSMotor Finance Update
1st Aug 20255:28 pmRNSTransaction in Own Shares
1st Aug 202512:00 pmRNSDirector/PDMR Shareholding
31st Jul 20255:49 pmRNSTotal Voting Rights
31st Jul 20255:28 pmRNSTransaction in Own Shares
31st Jul 20252:28 pmRNSNotice to the Series 2021-1 Covered Bondholders
30th Jul 20255:15 pmRNSTransaction in Own Shares
30th Jul 202510:46 amRNS2025 Half-Year Results
29th Jul 20256:11 pmRNSNotification of Redemption
29th Jul 20255:18 pmRNSTransaction in Own Shares
28th Jul 20255:26 pmRNSTransaction in Own Shares
25th Jul 20255:32 pmRNSTransaction in Own Shares
24th Jul 20255:18 pmRNSTransaction in Own Shares
24th Jul 20253:00 pmRNSPublication of Supplementary Prospectus
24th Jul 202512:21 pmRNSPublication of Supplementary Prospectus
24th Jul 202511:15 amRNS2025 Half-Year Results
24th Jul 202511:15 amRNS2025 Half-Year Results
24th Jul 202511:15 amRNS2025 Half-Year Results
24th Jul 20257:00 amRNS2025 Half-Year Results
23rd Jul 20255:51 pmRNSTransaction in Own Shares
22nd Jul 20255:42 pmRNSTransaction in Own Shares
21st Jul 20255:59 pmRNSTransaction in Own Shares
18th Jul 20255:37 pmRNSTransaction in Own Shares
17th Jul 20255:48 pmRNSTransaction in Own Shares
16th Jul 20255:49 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.